Cargando...
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo
Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...
Guardado en:
| Publicado en: | J Lipid Res |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The American Society for Biochemistry and Molecular Biology
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/ https://ncbi.nlm.nih.gov/pubmed/30782959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|